Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine before embryo transfer in ICSI cycles
IRCT20180417039338N3Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Recurrent Implantation Failure (RIF) and female infertility comparing Nifedipine with Placebo control (2 arms). Primary endpoint: Pregnancy rate. Started Mar 2018; status: completed.
02
Drugs
nifedipine
03
Conditions
Recurrent Implantation Failure (RIF)female infertility
Beyond the preview
Go deeper on IRCT20180417039338N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180417039338N3.